Skip to main content
Clinical Trials/IRCT2017020520351N9
IRCT2017020520351N9CompletedPhase 2

Evaluation of the effect of pretreatment of E2 and OCP before Antagonist cycle on IVF outcome.

Vice Chancellor for Research, Tehran University of Medical Sciences0 sites195 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
195

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 35 years (—)
Sex
Female

Inclusion Criteria

  • women with 20-35 years old; prior IVF less than 2; AFC>4; FSH<10; without any pathology in ovary or endometrioma more than 1cm; without any hydrosalpinx.
  • Exclusion criteria: PCOS; pathology in uterus or ovary ( myoma larger than 5 cm); absence of vaginal bleeding until 6 days after disconnection of OCP or E2; lack of permission of patients.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice Chancellor for Research, Tehran University of Medical Sciences

Similar Trials